Facioscapulohumeral Muscular Dystrophy (FSHD) Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Anesthetic management with remimazolam for laryngectomy in a severely underweight patient with facioscapulohumeral muscular dystrophy
Korean J Anesthesiol. 2023 Jun 2. doi: 10.4097/kja.23322. Online ahead of print.NO ABSTRACTPMID:37264584 | DOI:10.4097/kja.23322 (Source: Korean Journal of Anesthesiology)
Source: Korean Journal of Anesthesiology - June 2, 2023 Category: Anesthesiology Authors: Kwon Hui Seo Ji Yung Lee Source Type: research

SA7 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is a rare, debilitating disease for which there are no approved pharmacological interventions. As the disease progresses, patients lose upper limb function and mobility, which results in a decrease in the ability to perform activities of daily living and independence; patients often live with chronic pain. This systematic literature review assessed the existing evidence base regarding clinical, economic and humanistic outcomes in FSHD. (Source: Value in Health)
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: L. Barnieh, R. Beckerman, H. Emich, K. Eichinger, A. Eldar-Lissai Source Type: research

Molecular therapies: present and future in neuromuscular diseases
CONCLUSION: Clinical research in the field of molecular therapy of neuromuscular diseases is one of the pacesetters of modern precision medicine; however, challenges need to be seen, jointly addressed and overcome in the future.PMID:37221259 | DOI:10.1007/s00115-023-01495-3 (Source: Der Nervenarzt)
Source: Der Nervenarzt - May 23, 2023 Category: Neurology Authors: Andreas Ziegler Maggie C Walter Benedikt E Schoser Source Type: research

Test-retest reliability of three life balance measures in people with neuromuscular disease: the activity card sort-NL, the activity calculator, and the occupational balance questionnaire
Conclusion: All three tools showed good to excellent test-retest reliability in a sample of patients with FSHD or MM, which is promising for its use in clinical practice and research.PMID:37212794 | DOI:10.1080/09638288.2023.2213482 (Source: Disability and Rehabilitation)
Source: Disability and Rehabilitation - May 22, 2023 Category: Rehabilitation Authors: J M P Leenders A C H Geurts E M J Steultjens T L Packer E H C Cup Source Type: research

The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden
CONCLUSIONS: Overall, the Italian FSHD-HI is a valid and well-suited measurement of the multi-dimensional aspects of disease burden in FSHD patients.PMID:37194629 | DOI:10.1080/09638288.2023.2212181 (Source: Disability and Rehabilitation)
Source: Disability and Rehabilitation - May 17, 2023 Category: Rehabilitation Authors: Elena Carraro Lucia Catherine Greco Andrea Lizio Maria Beretta Susanna Pozzi Jacopo Casiraghi Stefano Becchiati Fatmira Beshiri Maria Chiara Frisoni Felicia Iossa Chad Heatwole Valeria Sansone Source Type: research